You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
九強生物(300406.SZ):與雅培中國簽署供應分銷協議
格隆匯 05-13 17:03

格隆匯5月13日丨九強生物(300406.SZ)公佈,公司雅培貿易(上海)有限公司(“雅培中國”)簽署《供應分銷協議》。

根據該協議的條款和條件,公司特此指定雅培中國為其合作產品獨家分銷商,負責向中國大陸地區推廣、銷售、分銷和交付生化診斷產品,雅培接受此授權。公司承認並同意,雅培中國可為本協議指定分銷商,他們權在未經公司批准的情況下,向中國大陸地區推銷及銷售產品。

雅培中國應按照協議和質量協議內容採購合作產品雙方同意,適用於產品的購買價格可以更改。

協議的初始有效期至20211231到期自動續簽12個月。如意圖在該協議期結束後不再續約,必須於該協議期結束前不少於12個月提供書面通知,説明其意圖。該協議可經雙方達成書面協議予以延長。如果雅培中國計劃從市場上撤出與生化診斷產品相配套的儀器,雅培中國可以提前一百八十天向公司提供書面通知後終止本協議。

此次深化合作表明公司的產品技術及質量控制體系被國際巨頭認可,將對公司的未來發展產生積極穩定的影響。同時,這也將促進九強生物在新產品研發方面的內生動力,為公司未來開拓國際市場奠定重要基礎。

作為中國醫療診斷行業中的龍頭企業之一,九強生物經過20多年的不斷創新和深耕,已經發展成為國內IVD生化產品最齊全、產品質量最過硬的企業之一。九強生物為雅培中國生化檢測平台提供完善、優質和靈活多樣的生化檢測菜單,有助於雅培中國的中國用户體驗提升,更好地滿足中國用户多方面多層次的需求。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account